Entry | H00881 Disease |
---|---|
Other DBs | ICD-11: 2B51.Y ICD-10: Z15 MeSH: D016864 OMIM: 151623 609265 |
Reference | PMID:19952748 |
Authors | Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P |
Title | Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. |
Diagnosis Index entries containing back-references to Z15.01: Family, familial - see also condition Li-Fraumeni Z15.01 (syndrome) Genetic susceptibility to disease NEC Z15.89 ICD-10-CM Diagnosis Code Z15.89 Susceptibility to disease, genetic Z15.89 ICD-10-CM Diagnosis Code Z15.89 Syndrome - see also Disease Li-Fraumeni Z15.01
Li-Fraumeni syndrome (lee-FRAH-meh-nee) is a rare hereditary or genetic disorder that increases the risk you and your family members will develop cancer. People who are female at birth who have Li-Fraumeni syndrome have a nearly 100% chance of developing breast cancer.
Li-Fraumeni syndrome happens when something changes in the TP53 gene, which contains the instruction manual to make a protein called tumor protein 53, or P53. Your P53 protein is a tumor suppressor. It keeps your cells from dividing and growing too quickly or in an uncontrolled way, becoming tumors.
People who are female at birth who have Li-Fraumeni syndrome have a nearly 100% chance of developing breast cancer. All people who have Li-Fraumeni syndrome have a 90% chance of developing one or more types of cancer in their lifetimes and a 50% chance of developing cancer before age 30. Li-Fraumeni syndrome can’t be prevented.
Codes from category Z15 should not be used as principal or first-listed codes.
Chromosomal abnormality, unspecified Q99. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Q99. 9 became effective on October 1, 2021.
ICD-10 code Z15. 01 for Genetic susceptibility to malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
Genetic susceptibility to other diseaseICD-10 code Z15. 89 for Genetic susceptibility to other disease is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Our physicians have used IDC-10 code F07. 81 as the primary diagnosis for patients presenting with post concussion syndrome.
Li-Fraumeni syndrome (lee-FRAH-meh-nee) is a rare hereditary or genetic disorder that increases the risk you and your family members will develop cancer. People who are female at birth who have Li-Fraumeni syndrome have a nearly 100% chance of developing breast cancer.
BRCA1 and/or 2 positive results are assigned either ICD-10-CM code Z15. 01 Genetic susceptibility to malignant neoplasm of breast or Z15. 02 Genetic susceptibility to malignant neoplasm of ovary, depending on family history.
Family history of carrier of genetic disease The 2022 edition of ICD-10-CM Z84. 81 became effective on October 1, 2021.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Per the ICD-10-CM classification, R92. 2 cannot be assigned with Z12. 31 because of an Excludes1 note under Z12. 31.
Applicable To. Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Common diagnosis codes for colorectal cancer screening include: Z12. 11 (encounter for screening for malignant neoplasm of colon) Z80.
Group 1CodeDescription77065DIAGNOSTIC MAMMOGRAPHY, INCLUDING COMPUTER-AIDED DETECTION (CAD) WHEN PERFORMED; UNILATERAL77066DIAGNOSTIC MAMMOGRAPHY, INCLUDING COMPUTER-AIDED DETECTION (CAD) WHEN PERFORMED; BILATERAL16 more rows
Z13. 820 Encounter for screening for osteoporosis - ICD-10-CM Diagnosis Codes.
Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
Approximately 80% of families with the features of Li-Fraumeni Syndrome (LFS) have an identifiable change ( mutation) in the TP53 gene. [1] . TP53 is a tumor suppressor gene, which means that it encodes a protein that stops cells from growing and dividing too rapidly or in an uncontrolled way.
Li-Fraumeni syndrome (LFS) is inherited in an autosomal dominant manner . [1] This means that a person only needs a change ( mutation) in one copy of the responsible gene in each cell to have LFS. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new ( de novo) mutations in the gene; these cases occur in people with no history of the disorder in their family. A person with LFS has a 50% chance with each pregnancy of passing along the altered gene to his or her child.
Li-Fraumeni syndrome (LFS) is an inherited condition that is characterized by an increased risk for certain types of cancer. Affected people often develop cancer at an earlier age than expected and may be diagnosed with more than one cancer during their lifetime. LFS is primarily associated with sarcomas (cancers of muscle, ...
It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
LFS is primarily associated with sarcomas (cancers of muscle, bone or connective tissue ), breast cancer, brain tumors, leukemia and adrenocortical carcinoma; however, many other types of cancer have been reported in people with this condition.
Li-Fraumeni syndrome (LFS) is an inherited condition that is characterized by an increased risk for certain types of cancer. Affected people often develop cancer at an earlier age than expected and may be diagnosed with more than one cancer during their lifetime. LFS is primarily associated with sarcomas (cancers of muscle, bone or connective tissue ), breast cancer, brain tumors, leukemia and adrenocortical carcinoma; however, many other types of cancer have been reported in people with this condition. [1] [2] It is caused by changes ( mutations) in the TP53 gene and is inherited in an autosomal dominant manner. [1] Management may include high-risk cancer screening and/or prophylactic surgeries. [1] [3]
Li-Fraumeni syndrome (LFS) is inherited in an autosomal dominant manner . [1] This means that a person only needs a change ( mutation) in one copy of the responsible gene in each cell to have LFS. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new ( de novo) mutations in the gene; these cases occur in people with no history of the disorder in their family. A person with LFS has a 50% chance with each pregnancy of passing along the altered gene to his or her child.
Z15.0. Non-Billable means the code is not sufficient justification for admission to an acute care hospital when used a principal diagnosis. Use a child code to capture more detail. ICD Code Z15.0 is a non-billable code.
Use Additional Code note means a second code must be used in conjunction with this code. Codes with this note are Etiology codes and must be followed by a Manifestation code or codes.